UPXI insider transaction filings
UPEXI, INC. — 21 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-20. Screen UPXI transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-20 | 4 | Dugan Lawrence — Director | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2026-07-20 | 4 | Rudick Brian Benjamin — Chief Strategy Officer | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2026-07-20 | 4 | Salkind Gene — Director | Grant/award (A): 100,000 @ $0 | EDGAR |
| 2026-07-20 | 4 | Norstrud Andrew James — Chief Financial Officer, Director | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2026-07-20 | 4 | MARSHALL ALLAN — Chief Executive Officer, Director | Grant/award (A): 2,000,000 @ $0 | EDGAR |
| 2025-12-23 | 4 | MARSHALL ALLAN — Chief Executive Officer, Director | Purchase (P): 50,000 @ $1.80 | EDGAR |
| 2025-12-17 | 4 | MARSHALL ALLAN — Chief Executive Officer, Director | Grant/award (A): 1,600,000 @ $0 · Purchase (P): 100,000 @ $2.07 · Purchase (P): 50,000 @ $2.07 | EDGAR |
| 2025-11-21 | 4 | Salkind Gene — Director | Purchase (P): 50,000 @ $2.55 | EDGAR |
| 2025-11-21 | 4 | Norstrud Andrew James — Chief Financial Officer, Director | Grant/award (A): 240,000 @ $0 | EDGAR |
| 2025-11-18 | 4 | Salkind Gene — Director | Purchase (P): 100,000 @ $2.65 · Purchase (P): 100,000 @ $2.81 | EDGAR |
| 2025-07-30 | 4 | Salkind Gene — Director, 10% owner | Purchase (P): 20,243 @ $4.94 · Grant/award (A): 50,000 @ $0 · Grant/award (A): 150,000 @ $0 | EDGAR |
| 2025-07-24 | 4 | Rudick Brian Benjamin — CSO | Grant/award (A): 400,000 @ $0 | EDGAR |
| 2025-07-24 | 4 | Dugan Lawrence — Director | Purchase (P): 1,000 @ $5.17 · Grant/award (A): 50,000 @ $0 · Grant/award (A): 50,000 @ $0 · Purchase (P): 10,000 @ $5.70 · Purchase (P): 1,000 @ $5.60 · Purchase (P): 4,000 @ $7.50 | EDGAR |
| 2025-07-24 | 4 | Williams Thomas Charles — Director | Grant/award (A): 50,000 @ $0 · Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-07-24 | 4 | Norstrud Andrew James — Chief Financial Officer, Director | Grant/award (A): 250,000 @ $0 | EDGAR |
| 2025-07-24 | 4 | MARSHALL ALLAN — Chief Executive Officer, Director, 10% owner | Purchase (P): 161,943 @ $4.94 · Grant/award (A): 1,200,000 @ $0 | EDGAR |
| 2025-04-25 | 4 | Dugan Lawrence — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | Salkind Gene — Director, 10% owner | Purchase (P): 241,229 @ $2.28 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 35,000 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | Williams Thomas Charles — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-04-25 | 4 | Norstrud Andrew James — Chief Financial Officer, Director | Purchase (P): 43,860 @ $2.28 · Grant/award (A): 100,000 @ $0 | EDGAR |
| 2025-04-25 | 4 | MARSHALL ALLAN — Chief Executive Officer, Director, 10% owner | Purchase (P): 657,895 @ $2.28 · Grant/award (A): 75,000 @ $0 · Purchase (P): 125,000 (derivative) @ $2.60 · Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — UPEXI, INC.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-31 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-16 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-07 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-12 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=UPXI returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →